Patent · US Active

Compounds for treatment of cancer

US9029408B2 · kind B2 · utility

12Cited by
9References
30Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 9, 2013
Grant dateMay 12, 2015
Priority date
Expiry dateOct 9, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.